All researches including human or animal subjects, needs approval by a corresponding ethical compliance body and the section of ethics approval is necessary to augment the legitimacy of research findings. In this way, the name of the ethics committee that approved the investigation and the committee’s reference number are required.
Research involving human material, human participants, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Further information and documentation to support this should be made available to the Editor on request. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, the Editor may contact the ethics committee for further information.
If a study has not been granted ethics committee approval prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. The decision on whether to proceed to peer review in such cases is at the Editor's discretion.
Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.
For all research involving human participants, informed consent to participate in the study should be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. For manuscripts reporting studies involving vulnerable groups (for example, unconscious patients) where there is the potential for coercion (for example prisoners) or where consent may not have been fully informed, manuscripts will be considered at the editor’s discretion and may be referred to an internal editorial oversight group for further scrutiny. Consent must be obtained for all forms of personally identifiable data including biomedical, clinical, and biometric data. In the case of articles describing human transplantation studies, authors must include a statement declaring that no organs/tissues were obtained from prisoners and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained. Documentary evidence of consent must be supplied if requested.
General Declaration
Micro Nano Bio Aspects (MNBA) strongly considers the "ethical standards for publication" to ensure upon the "high-quality scientific publications", which grants the public trust for the scientific findings as the proof-of-concept and the proof-of-transformative technology. MNBA follows Helsinki Declaration. Click to read the Ethical Principles for Medical Research Involving Human Subjects.
MNBA restrictedly adheres to the “Code of Conduct” and the “Best Practice Guidelines” and "Principles of Transparency and Best Practice in Scholarly Publishing".
Click to visit the “Code of Conduct and the Best Practice Guidelines for Journal Editors” provided by COPE.
Click to visit the “Core Practices for Journal Publishers”.
Plagiarism, Duplicated Publication, Data Fabrication and Falsification
MNBA is committed to publishing the original studies and timely reviews that have neither been published nor is under review elsewhere. MNBA is powered by iThenticate™ and Plagiarism Checker X™. Taken all, all plagiarized materials will incur the “Plagiarism Sanctions”.
Submitted MSs, which are found to be published or under review elsewhere, will be sustained and experience the “Duplicated Publication Sanctions”.
Submitted MSs, which are found to include either fabricated or falsified data including the manipulation of images, will confront with the “Data Fabrication/Falsification Sanctions”.
Redundant Publications
All the redundant publications, which are involved in an inappropriate dividing of study outcomes into several articles, will face the “Redundant Publication Sanctions”.
Citation Manipulation
All the submitted MSs found to have manipulated citations primarily for just increasing the number of citations to a given author(s) or article(s) will incur the “Citation Manipulation Sanctions”.
Gift Authorship
All listed authors are required to have significant scientific contributions to the research of the submitted MS and also approved the claimed findings. Gift Authorship, an author without any significant scientific contribution, will meet with the “Gift Authorship Sanctions”.
According to the ICMJE, the authorship should be based on the following criteria:
Retraction
Based on the COPE guidelines on the retraction, MNBA will consider retracting a publication if:
Sanctions
In the case of occurrence documented violations of the aforementioned policies of the journal, it is the MNBA’s right to apply the following sanctions: